cannabi hope drug firmprescript cannabi drug made uk biotech firm gw pharmaceut set approv canadadrug use treat central nervous system allevi symptom multipl sclerosi ms week ago share gw pharma lost third valu uk regul said want evid drug benefit now canadian author said sativex drug will consid approvapproxim 50000 peopl canada diagnos ms 85000 peopl suffer condit uk mani patient alreadi smoke cannabi reliev symptomnow gw pharma sativex mouth spray legal avail ms suffer canada within next month will first time cannabisbas drug approv anywher world repres landmark gw pharma patient ms final approv canada now littl formal analyst said compani expect full approv sativex earli 2005 delight receiv qualifi notic health canada look forward receiv regulatori approv sativex canada earli part 2005 said gw pharma execut chairman dr geoffrey guyuk govern grant gw pharma licenc grow cannabi plant medic research purpos satifex consist cannabi extract contain tetrahydrocannabinol cannabidiol cocktail also prove effect treat patient arthriti thousand plant grown secret locat somewher english countrysid despit hope regulatori approv last year seri delay put back sativex launch uk latest news sent share gw pharma 85p 81 1135p